Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Oncotarget
|
January 7, 2017
25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
Sung-Min Kim, Min-Young Noh, Heejaung Kim, et al.
Neurochemical Research
|
October 15, 2015
Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6
Ji-Eun Seo, Mahbub Hasan, Joon-Seung Han, et al.
Journal of Medicinal Chemistry
|
October 29, 2013
Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy
Min Jeong Choi, Eun Sun No, Dhanaji Achyutrao Thorat, et al.
Journal of Medicinal Chemistry
|
December 13, 2018
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy
Ji Won Choi, Siwon Kim, Jong-Hyun Park, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2013
Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease
Hye Ri Park, Jiyoon Kim, Taekeun Kim, et al.
Journal of Medicinal Chemistry
|
August 25, 2025
Discovery of Novel β-Arrestin Biased Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis
Chang Yong Lee, Lizaveta Gotina, Jushin Kim, et al.
Journal of Medicinal Chemistry
|
March 10, 2026
Design, Synthesis, and Biological Evaluation of Novel Vinyl Selenone Derivatives as Potent Nrf2 Activators for Atopic Dermatitis
Jushin Kim, Yoowon Kim, Byungeun Kim, et al.
Journal of Medicinal Chemistry
|
July 25, 2023
Exploration of Tetrahydroisoquinoline- and Benzo[<i>c</i>]azepine-Based Sphingosine 1-Phosphate Receptor 1 Agonists for the Treatment of Multiple Sclerosis
Eunji Cha, Jushin Kim, Lizaveta Gotina, et al.
Journal of Medicinal Chemistry
|
January 29, 2014
Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy
Seo Yeon Woo, Ji Hyun Kim, Mi Kyeong Moon, et al.
Neuropharmacology
|
February 8, 2020
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
Siwon Kim, Ambily Nath Indu Viswanath, Jong-Hyun Park, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Oncotarget
|
January 7, 2017
25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
Sung-Min Kim, Min-Young Noh, Heejaung Kim, et al.
Neurochemical Research
|
October 15, 2015
Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6
Ji-Eun Seo, Mahbub Hasan, Joon-Seung Han, et al.
Journal of Medicinal Chemistry
|
October 29, 2013
Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy
Min Jeong Choi, Eun Sun No, Dhanaji Achyutrao Thorat, et al.
Journal of Medicinal Chemistry
|
December 13, 2018
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy
Ji Won Choi, Siwon Kim, Jong-Hyun Park, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2013
Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease
Hye Ri Park, Jiyoon Kim, Taekeun Kim, et al.
Journal of Medicinal Chemistry
|
August 25, 2025
Discovery of Novel β-Arrestin Biased Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis
Chang Yong Lee, Lizaveta Gotina, Jushin Kim, et al.
Journal of Medicinal Chemistry
|
March 10, 2026
Design, Synthesis, and Biological Evaluation of Novel Vinyl Selenone Derivatives as Potent Nrf2 Activators for Atopic Dermatitis
Jushin Kim, Yoowon Kim, Byungeun Kim, et al.
Journal of Medicinal Chemistry
|
July 25, 2023
Exploration of Tetrahydroisoquinoline- and Benzo[<i>c</i>]azepine-Based Sphingosine 1-Phosphate Receptor 1 Agonists for the Treatment of Multiple Sclerosis
Eunji Cha, Jushin Kim, Lizaveta Gotina, et al.
Journal of Medicinal Chemistry
|
January 29, 2014
Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy
Seo Yeon Woo, Ji Hyun Kim, Mi Kyeong Moon, et al.
Neuropharmacology
|
February 8, 2020
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
Siwon Kim, Ambily Nath Indu Viswanath, Jong-Hyun Park, et al.
Page
of 8